Retreatment with trastuzumab in HER-2 positive metastatic breast cancer progressing after trastuzumab and lapatinib

Abstract

Retreatment with trastuzumab in HER-2 positive metastatic breast cancer progressing after trastuzumab and lapatinib has been attempted in several prospective and retrospective studies.

Keywords

• breast cancer
• trastuzumab